Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical.

Détails

ID Serval
serval:BIB_79E8BD59ECDD
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Lettre (letter): communication adressée à l'éditeur.
Collection
Publications
Titre
Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical.
Périodique
Clinical microbiology and infection
Auteur(s)
Orasch C., Averbuch D., Mikulska M., Cordonnier C., Livermore D.M., Gyssens I.C., Klyasova G., Engelhard D., Kern W., Viscoli C., Akova M., Marchetti O.
Collaborateur(s)
4th European Conference on Infections in Leukemia (ECIL-4), joint venture of Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (IDWP-EBMT), Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (IDG-EORTC), International Immunocompromised Host Society (ICHS), European Leukemia Net (ELN) and European Study Group on Infections in Immunocompromised Hosts of the European Society for Clinical Microbiology and Infectious Diseases (ESGICH-ESCMID)
ISSN
1469-0691 (Electronic)
ISSN-L
1198-743X
Statut éditorial
Publié
Date de publication
03/2015
Peer-reviewed
Oui
Volume
21
Numéro
3
Pages
e25-7
Langue
anglais
Notes
Publication types: Comment ; Letter
Publication Status: ppublish
Mots-clé
Anti-Bacterial Agents/therapeutic use, Female, Fever of Unknown Origin/drug therapy, Humans, Leukemia, Myeloid, Acute/complications, Male, Neutropenia/complications, Withholding Treatment/ethics
Pubmed
Open Access
Oui
Création de la notice
13/02/2015 9:44
Dernière modification de la notice
08/05/2019 20:44
Données d'usage